Return to top of page

Preparing for the Patient-Focused Drug Development Meeting on Sarcopenia

Published February 17, 2017

The U.S. Food & Drug Administration (FDA) holds a public meeting on April 6, 2017, to hear directly from patients, caregivers, and advocates about sarcopenia. This Patient-Focused Drug Development (PFDD) Meeting is a rare opportunity to talk with the FDA about what it is like to live with the condition and how improved treatment could impact your life. This Aging In Motion (AIM) Coalition webinar provides background on the FDA’s PFDD Initiative, details what will be expected of participants at this meeting, and highlights real patient experiences from a PFDD meeting.

Learn more at https://www.aginginmotion.org/.